Peripheral arterial function in infants and young children with one-ventricle physiology and hypoxemia

Shobha Natarajan1, Christian Heiss, Yerem Yeghiazarians

  • 1Division of Pediatric Cardiology, University of California San Francisco, San Francisco, CA, USA. natarajans@email.chop.edu

Insights

Infants with single-ventricle (1V) physiology and hypoxemia show impaired brachial artery flow-mediated dilation (FMD) and elevated endothelin-1 (ET-1) levels before the Fontan procedure, indicating early peripheral arterial dysfunction.

Area of Science:

  • Cardiovascular Research
  • Pediatric Cardiology
  • Vascular Biology

Background:

  • Single-ventricle (1V) physiology poses risks for peripheral arterial dysfunction in young patients.
  • Early identification of vascular issues is crucial for long-term outcomes in 1V patients.

Purpose of the Study:

  • To assess peripheral arterial dysfunction in infants and young children with 1V physiology and hypoxemia before the Fontan operation.
  • To compare vascular parameters between 1V patients and healthy controls.

Main Methods:

  • Measured flow-mediated dilation (FMD) of the brachial artery using high-resolution ultrasound.
  • Quantified serum levels of endothelin-1 (ET-1) and nitric oxide metabolites.
  • Assessed arterial stiffness via pulse-wave velocity (PWV) in the aorta.

Main Results:

  • Patients with 1V physiology exhibited significantly lower FMD (2.4% vs. 11.3%, p <0.0005).
  • Elevated ET-1 levels were observed in 1V patients compared to controls (35.5% vs. 24.1%, p = 0.003).
  • No significant differences in nitric oxide levels or PWV were found between groups.

Conclusions:

  • Infants and young children with 1V physiology and hypoxemia demonstrate blunted FMD and increased ET-1 levels pre-Fontan operation.
  • These findings suggest peripheral arterial dysfunction is present early in 1V physiology.
  • Further research into hypoxemia, low cardiac index, and ET-1's role may guide targeted therapies for improved survival in 1V patients.